Mechanism of supraventricular tachycardia
Mechanism of supraventricular tachycardia Supraventricular tachycardia (SVT) is a common arrhythmia characterized by a rapid heart rate originating above the ventricles, typically in the atria or atrioventricular (AV) node. Understanding the mechanisms underlying SVT is essential for accurate diagnosis and effective treatment. At its core, SVT involves abnormal electrical activity within the heart’s conduction system, leading to a reentrant circuit or ectopic pacemaker activity that causes the heart to beat rapidly and often irregularly.
Mechanism of supraventricular tachycardia The heart’s electrical system is designed to generate and conduct impulses in a coordinated manner, ensuring efficient blood flow. The sinoatrial (SA) node serves as the primary pacemaker, initiating impulses that spread through the atria, then to the AV node, and onward to the ventricles via the His-Purkinje system. In SVT, this sequence is disrupted by abnormal electrical pathways or activity. Two main mechanisms are involved: reentry and enhanced automaticity.
Reentry is the most common mechanism underlying SVT. It involves the presence of an electrical circuit within the heart tissue, where impulses continuously circulate, producing rapid firing. For reentry to occur, there must be two pathways with differing conduction velocities and refractory periods. Typically, one pathway may conduct impulses faster, while the other may have a delay or block. When a premature atrial beat or other trigger occurs, it can initiate a self-sustaining loop if the impulse travels down one pathway and reenters via another that has recovered excitability. This creates a reentrant circuit, often involving the AV node or accessory pathways, leading to sustained tachycardia. For example, in atrioventricular nodal reentrant tachycardia (AVNRT), the circuit is confined within or around the AV node, involving dual pathways with different conduction properties. Mechanism of supraventricular tachycardia
Enhanced automaticity, another mechanism, involves abnormal pacemaker activity outside the SA node, typically in atrial tissues. Such ectopic foci can spontaneously generate impulses at a rate faster than the normal sinoatrial rhythm, leading to episodes of SVT. This mechanism is less common but can contribute to arrhythmias, especially in diseased atrial tissue. Mechanism of supraventricular tachycardia
Mechanism of supraventricular tachycardia Accessory pathways, such as those in Wolff-Parkinson-White (WPW) syndrome, also play a significant role. These abnormal conduction pathways directly connect the atria and ventricles, bypassing the AV node. During episodes of SVT, impulses can travel antegradely down the accessory pathway and retrogradely back to the atria, creating a reentrant circuit that results in rapid heart rates.
Understanding these mechanisms helps clinicians tailor treatments. For instance, medications like beta-blockers and calcium channel blockers aim to slow conduction through the AV node, interrupting reentrant circuits. Catheter ablation targets and destroys aberrant pathways or focal automatic sites, offering a potential cure. Mechanism of supraventricular tachycardia
In summary, supraventricular tachycardia primarily results from reentrant circuits involving the AV node or accessory pathways, or from abnormal automaticity in atrial tissues. Recognizing these mechanisms is key to effective management and improving patient outcomes.
